136 related articles for article (PubMed ID: 38756571)
1. Up-regulated ORC1 promotes lung adenocarcinoma by inhibiting ferroptosis via SLC7A11 dependent pathway.
Ming L; Han Z; Ai Z; Yang X; Lin F; Zhang N; Hao W
Heliyon; 2024 May; 10(9):e30506. PubMed ID: 38756571
[TBL] [Abstract][Full Text] [Related]
2. Origin recognition complex subunit 1 (ORC1) augments malignant behaviors of lung adenocarcinoma cells via targeting Wnt signaling.
Han L; Li F
Bioengineered; 2022 May; 13(5):13520-13533. PubMed ID: 36700467
[TBL] [Abstract][Full Text] [Related]
3. Hsa_circ_0070440 promotes lung adenocarcinoma progression by SLC7A11-mediated-ferroptosis.
Zhao Y; Cui Q; Shen J; Shen W; Weng Y
Histol Histopathol; 2023 Dec; 38(12):1429-1441. PubMed ID: 36852950
[TBL] [Abstract][Full Text] [Related]
4. METTL3 promotes lung adenocarcinoma tumor growth and inhibits ferroptosis by stabilizing SLC7A11 m
Xu Y; Lv D; Yan C; Su H; Zhang X; Shi Y; Ying K
Cancer Cell Int; 2022 Jan; 22(1):11. PubMed ID: 34996469
[TBL] [Abstract][Full Text] [Related]
5. A Comprehensive Prognostic and Immune Analysis of Ferroptosis-Related Genes Identifies SLC7A11 as a Novel Prognostic Biomarker in Lung Adenocarcinoma.
Qian L; Wang F; Lu SM; Miao HJ; He X; Feng J; Huang H; Shi RF; Zhang JG
J Immunol Res; 2022; 2022():1951620. PubMed ID: 35509981
[TBL] [Abstract][Full Text] [Related]
6. CircP4HB regulates ferroptosis via SLC7A11-mediated glutathione synthesis in lung adenocarcinoma.
Pan CF; Wei K; Ma ZJ; He YZ; Huang JJ; Guo ZZ; Chen ZP; Barr MP; Shackelford RE; Xia Y; Wang J
Transl Lung Cancer Res; 2022 Mar; 11(3):366-380. PubMed ID: 35399564
[TBL] [Abstract][Full Text] [Related]
7. SLC7A11 inhibits ferroptosis and downregulates PD-L1 levels in lung adenocarcinoma.
Huang Z; Chen X; Wang Y; Yuan J; Li J; Hang W; Meng H
Front Immunol; 2024; 15():1372215. PubMed ID: 38655266
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of CCT3 predicts poor prognosis and promotes cell proliferation via inhibition of ferroptosis and activation of AKT signaling in lung adenocarcinoma.
Wang K; He J; Tu C; Xu H; Zhang X; Lv Y; Song C
BMC Mol Cell Biol; 2022 Jun; 23(1):25. PubMed ID: 35773623
[TBL] [Abstract][Full Text] [Related]
9. Bulk RNA-seq and scRNA-seq reveal SLC7A11, a key regulatory molecule of ferroptosis, is a prognostic-related biomarker and highly related to the immune system in lung adenocarcinoma.
Wu X; Wang S; Chen K
Medicine (Baltimore); 2023 Sep; 102(37):e34876. PubMed ID: 37713821
[TBL] [Abstract][Full Text] [Related]
10. [Effect of SLC7A11 gene downregulation on the gefitinib resistance of lung adenocarcinoma PC9/GR cells and its mechanism].
Jia YL; Zhao Y; Zhen SM; Cheng ZS; Zheng BY; Liu YP; Liu LH
Zhonghua Zhong Liu Za Zhi; 2023 Sep; 45(9):779-786. PubMed ID: 37805442
[No Abstract] [Full Text] [Related]
11. [Mechanism of miR-186-5p Regulating PRKAA2 to Promote Ferroptosis
in Lung Adenocarcinoma Cells].
Liu L; Guan X; Zhao Y; Wang X; Yin C; Liu Q; Li H
Zhongguo Fei Ai Za Zhi; 2023 Nov; 26(11):813-821. PubMed ID: 38061883
[TBL] [Abstract][Full Text] [Related]
12. Tetrandrine citrate suppresses lung adenocarcinoma growth via SLC7A11/GPX4-mediated ferroptosis.
Mo X; Hu D; Yuan K; Luo J; Huang C; Xu M
Discov Oncol; 2023 Jun; 14(1):85. PubMed ID: 37266741
[TBL] [Abstract][Full Text] [Related]
13. Targeting SLC3A2 subunit of system X
Ma L; Zhang X; Yu K; Xu X; Chen T; Shi Y; Wang Y; Qiu S; Guo S; Cui J; Miao Y; Tian X; Du L; Yu Y; Xia J; Wang J
Free Radic Biol Med; 2021 May; 168():25-43. PubMed ID: 33785413
[TBL] [Abstract][Full Text] [Related]
14. Super-enhancer mediated upregulation of MYEOV suppresses ferroptosis in lung adenocarcinoma.
Luo S; Luo Y; Wang Z; Yin H; Wu Q; Du X; Xie X
Cancer Lett; 2024 May; 589():216811. PubMed ID: 38490328
[TBL] [Abstract][Full Text] [Related]
15. Ferroptosis and WDFY4 as novel targets for immunotherapy of lung adenocarcinoma.
Huang L; Zhong L; Cheng R; Chang L; Qin M; Liang H; Liao Z
Aging (Albany NY); 2023 Sep; 15(18):9676-9694. PubMed ID: 37728413
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-147b promotes lung adenocarcinoma cell aggressiveness through negatively regulating microfibril-associated glycoprotein 4 (MFAP4) and affects prognosis of lung adenocarcinoma patients.
Feng YY; Liu CH; Xue Y; Chen YY; Wang YL; Wu XZ
Gene; 2020 Mar; 730():144316. PubMed ID: 31884109
[TBL] [Abstract][Full Text] [Related]
17. PHGDH Inhibits Ferroptosis and Promotes Malignant Progression by Upregulating SLC7A11 in Bladder Cancer.
Shen L; Zhang J; Zheng Z; Yang F; Liu S; Wu Y; Chen Y; Xu T; Mao S; Yan Y; Li W; Zhang W; Yao X
Int J Biol Sci; 2022; 18(14):5459-5474. PubMed ID: 36147463
[No Abstract] [Full Text] [Related]
18. EZH2-mediated SLC7A11 upregulation via miR-125b-5p represses ferroptosis of TSCC.
Yu Y; MohamedAl-Sharani H; Zhang B
Oral Dis; 2023 Apr; 29(3):880-891. PubMed ID: 34614259
[TBL] [Abstract][Full Text] [Related]
19. SLC7A11 promotes the progression of gastric cancer and regulates ferroptosis through PI3K/AKT pathway.
Jiang Y; Cui J; Cui M; Jing R
Pathol Res Pract; 2023 Aug; 248():154646. PubMed ID: 37399587
[TBL] [Abstract][Full Text] [Related]
20. The N6-methyladenosine modification enhances ferroptosis resistance through inhibiting SLC7A11 mRNA deadenylation in hepatoblastoma.
Liu L; He J; Sun G; Huang N; Bian Z; Xu C; Zhang Y; Cui Z; Xu W; Sun F; Zhuang C; Man Q; Gu S
Clin Transl Med; 2022 May; 12(5):e778. PubMed ID: 35522946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
